Breaking News Instant updates and real-time market news.

VRX

Valeant

$23.81

0.38 (1.62%)

07:04
01/12/18
01/12
07:04
01/12/18
07:04

Ortho Dermatologics: FDA accepts NDA for IDP-121

Ortho Dermatologics, a division of Valeant Pharmaceuticals, announced that the U.S. FDA has accepted the New Drug Application for IDP-121 (tretinoin 0.05%) lotion with a PDUFA action date of Aug. 27, 2018. If approved, ALTRENO will be the first tretinoin product in lotion form rather than a gel or cream.

  • 18

    Jun

VRX Valeant
$23.81

0.38 (1.62%)

12/21/17
GSCO
12/21/17
NO CHANGE
GSCO
Valeant operational, capital structure momentum to continue, says Goldman Sachs
Goldman Sachs analyst Jonathan Kahnowitz notes that Valeant equity has rallied 90%, driven by better-than-expected operating results and recent capital markets transactions, which demonstrated the company's ability to manage its near-dated maturities. The analyst thinks the recent move in the equity, along with the strong performance in credit over the course of the year, raises the likelihood of additional refinancing transactions, a key driver of Kahnowitz's positive view on the credit. Further, the analyst notes that Valeant has seen important operational and capital structure momentum in recent months, which he thinks will continue to give the company the ability to manage its upcoming maturities and bridge to a more substantial deleveraging after 2018.
12/22/17
CANT
12/22/17
NO CHANGE
CANT
Cantor ups price targets for Teva, Valeant, Mylan, Zoetis
Cantor Fitzgerald analyst Louise Chen raised her price target for Neutral-rated Teva (TEVA) to $18 from $10, for Overweight-rated Valeant (VRX) to $25 from $23, for Neutral-Mylan (MYL) to $41 from $34 and for Overweight-rated Zoetis (ZTS) to $85 from $80. Heading into 2018, the analyst believes Perrigo (PRGO) has the best setup in the Specialty Pharmaceuticals space. The company has given the most visibility on its outlook for 2018, Chen tells investors in a research note. She believes Zoetis, Mylan and Horizon Pharma (HZNP) also look good into next year.
01/04/18
WELS
01/04/18
NO CHANGE
WELS
Underperform
Valeant litigation risks shouldn't be considered over, says Wells Fargo
Wells Fargo analyst David Maris noted that Valeant and co-defendant Pershing Square recently announced a $290M settlement in the Allergan shareholder insider trading litigation, but he cautions that investors shouldn't consider the bulk of Valeant's litigation risks behind it. The company is still facing ongoing investigations by both the SEC and a U.S. Attorney's Office, along with other class action and RICO suits, stated Maris, who maintains his Underperform rating on Valeant shares.
01/05/18
TDSI
01/05/18
NO CHANGE
Target $27
TDSI
Buy
Valeant price target raised to $27 from $20 at TD Securities
TD Securities analyst Lennox Gibbs raised his price target for Valeant Pharmaceuticals to $27 from $20 citing the company's operating momentum. The drugmaker closed yesterday down up 4c to $23.05. The analyst keeps a Buy rating on Valeant and lowered his risk rating on the shares to High from Speculative. Gibbs sees concerns over Valeant's balance sheet receding and interest in its organic prospects growing. The company's "strong progress on debt has significantly improved its risk profile," the analyst tells investors in a research note. He believes Valeant's core franchises are performing and highlights the "meaningful" launch of two new drugs since July 2017, Vyzulta and Siliq.

TODAY'S FREE FLY STORIES

ICE

IntercontinentalExchange

$72.36

0.82 (1.15%)

06:05
05/22/18
05/22
06:05
05/22/18
06:05
Periodicals
Stacey Cunningham to become NYSE's next president, WSJ reports »

Stacey Cunningham, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.97

-0.0099 (-1.01%)

06:04
05/22/18
05/22
06:04
05/22/18
06:04
Hot Stocks
DelMar Pharmaceuticals appoints Saiid Zarrabian to full-time CEO »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

VAR

Varian Medical

$118.75

0.3 (0.25%)

06:03
05/22/18
05/22
06:03
05/22/18
06:03
Hot Stocks
Varian notifies Sirtex it will not submit counterproposal to competing bid »

Varian announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$73.63

0.79 (1.08%)

06:03
05/22/18
05/22
06:03
05/22/18
06:03
Recommendations
Tractor Supply analyst commentary  »

Tractor Supply price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

PLAB

Photronics

$8.45

0.5 (6.29%)

06:02
05/22/18
05/22
06:02
05/22/18
06:02
Earnings
Photronics sees Q3 EPS 12c-18c, consensus 9c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

PPBI

Pacific Premier

$42.30

0.35 (0.83%)

06:01
05/22/18
05/22
06:01
05/22/18
06:01
Hot Stocks
Pacific Premier receives stockholder approval for issuance of shares »

Pacific Premier Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

TOL

Toll Brothers

$43.60

0.43 (1.00%)

06:01
05/22/18
05/22
06:01
05/22/18
06:01
Hot Stocks
Toll Brothers sees Q3 deliveries between 2,100 and 2,200 units »

Toll Brothers expects FY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

PLAB

Photronics

$8.45

0.5 (6.29%)

06:01
05/22/18
05/22
06:01
05/22/18
06:01
Earnings
Photronics reports Q2 EPS 15c, consensus 7c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

TOL

Toll Brothers

$43.60

0.43 (1.00%)

06:00
05/22/18
05/22
06:00
05/22/18
06:00
Earnings
Toll Brothers sees FY18 revenue $6.64B-$7.31B, consensus $6.97B »

Based on FY 2018's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

GRUB

GrubHub

$103.64

-0.145 (-0.14%)

05:58
05/22/18
05/22
05:58
05/22/18
05:58
Recommendations
GrubHub analyst commentary  »

GrubHub price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 12

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

05:58
05/22/18
05/22
05:58
05/22/18
05:58
Periodicals
U.S., China reach broad outline on deal to settle ZTE controversy, WSJ reports »

The U.S. and China have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HURN

Huron

$38.30

0.65 (1.73%)

05:57
05/22/18
05/22
05:57
05/22/18
05:57
Conference/Events
Huron management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

TOL

Toll Brothers

$43.60

0.43 (1.00%)

05:57
05/22/18
05/22
05:57
05/22/18
05:57
Earnings
Toll Brothers reports Q2 EPS 72c, consensus 76c »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

WWE

WWE

$57.86

6.37 (12.37%)

05:56
05/22/18
05/22
05:56
05/22/18
05:56
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WD

Walker & Dunlop

$56.10

1.07 (1.94%)

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 31

    May

BUD

AB InBev

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Upgrade
AB InBev rating change  »

AB InBev upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.75

2.8 (1.41%)

, BAYRY

Bayer

$0.00

(0.00%)

05:55
05/22/18
05/22
05:55
05/22/18
05:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

MMM

3M

$201.75

2.8 (1.41%)

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$228.74

3.73 (1.66%)

BIIB

Biogen

$277.69

-2.66 (-0.95%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

TEVA

Teva

$21.09

-0.14 (-0.66%)

UTHR

United Therapeutics

$104.12

-2.2 (-2.07%)

VCYT

Veracyte

$6.45

(0.00%)

VRTX

Vertex

$156.15

-1.09 (-0.69%)

NBRV

Nabriva Therapeutics

$4.54

-0.89 (-16.39%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

GSK

GlaxoSmithKline

$40.05

0.005 (0.01%)

HRC

Hill-Rom

$90.70

0.12 (0.13%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CELG

Celgene

$74.69

-3.7 (-4.72%)

JAZZ

Jazz Pharmaceuticals

$166.01

-1.59 (-0.95%)

ISRG

Intuitive Surgical

$463.18

4.3 (0.94%)

INSM

Insmed

$26.34

-2.16 (-7.58%)

REGN

Regeneron

$296.58

-5.29 (-1.75%)

OCX

OncoCyte

$2.50

-0.05 (-1.96%)

FGEN

FibroGen

$52.55

1.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 20

    Oct

  • 20

    Dec

CCJ

Cameco

$11.38

0.015 (0.13%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Cameco rating change  »

Cameco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$38.17

0.77 (2.06%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Teradyne management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

RTN

Raytheon

$213.95

2.88 (1.36%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Downgrade
Raytheon rating change  »

Raytheon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$11.96

-0.41 (-3.31%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPSC

SPS Commerce

$71.88

0.11 (0.15%)

05:53
05/22/18
05/22
05:53
05/22/18
05:53
Conference/Events
SPS Commerce management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 29

    May

  • 12

    Jun

RDCM

Radcom

$19.65

0.25 (1.29%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Conference/Events
Radcom management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 24

    May

  • 29

    May

INFO

IHS Markit

$51.60

0.13 (0.25%)

05:52
05/22/18
05/22
05:52
05/22/18
05:52
Upgrade
IHS Markit rating change  »

IHS Markit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$30.89

-2.66 (-7.93%)

05:51
05/22/18
05/22
05:51
05/22/18
05:51
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.